SCHEMBL24072305

SCHEMBL24072305

CC(C)c1ccccc1C(=O)Nc1ncc(N=O)s1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNE1 P24864 5/20 0.49
▸ CDK2 P24941 5/20 0.49
▸ CDK5 Q00535 5/20 0.49
▸ ALDH1A1 P00352 5/20 0.45
▸ USP2 O75604 1/20 0.45
▸ POLQ O75417 1/20 0.43
▸ KDR P35968 1/20 0.43
▸ STAT3 P40763 3/20 0.43
▸ NPC1 O15118 3/20 0.42
▸ RAB9A P51151 3/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ POLB P06746 1/20 0.42
▸ KCNK3 O14649 2/20 0.41
▸ KCNK9 Q9NPC2 2/20 0.41
▸ PKM P14618 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ CCNT1 O60563 1/20 0.41
▸ CDK1 P06493 1/20 0.41
▸ CDK4 P11802 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27134412 0.85 CCNE1 (0.44) CCNE1CDK2CDK5ALDH1A1USP2
SCHEMBL24074429 0.84 RAB9A (0.52) ALDH1A1STAT3NPC1RAB9APOLB
SCHEMBL24072396 0.84 STAT3 (0.44) CCNE1CDK2CDK5ALDH1A1KDR
SCHEMBL24073805 0.83 NPC1 (0.47) CCNE1CDK2CDK5ALDH1A1USP2
SCHEMBL24073667 0.83 CCNE1 (0.44) CCNE1CDK2CDK5ALDH1A1KDR
SCHEMBL27135218 0.83 CYP1A2 (0.55) CCNE1CDK2CDK5ALDH1A1KDR
SCHEMBL19632762 0.83 STAT3 (0.61) ALDH1A1KDRSTAT3NPC1RAB9A
SCHEMBL27134415 0.82 RAB9A (0.44) CCNE1CDK2CDK5ALDH1A1KDR
SCHEMBL24074140 0.82 NPC1 (0.56) CCNE1CDK2CDK5ALDH1A1KDR
SCHEMBL27134428 0.82 NPC1 (0.62) ALDH1A1STAT3NPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 — — US disclosed
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 — — US disclosed
WO-2021239117-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI) , INC. (CN) 2021-12-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 CCNE1 696/4885CDK2 500/4885CDK5 1532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback